Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 7Sarcoma 6Lymphoma 6Testicular Neoplasms 5Testicular Germ Cell Tumor 5Ovarian Neoplasms 5Osteosarcoma 5Lymphoma, Follicular 5Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Anaplastic 4Burkitt Lymphoma 4Recurrence 3Lymphoma, Large-Cell, Immunoblastic 3Immunoblastic Lymphadenopathy 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Teratoma 2Solitary Fibrous Tumors 2Small Cell Lung Carcinoma 2Sarcoma, Clear Cell 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hemangiosarcoma 2Hemangioendothelioma, Epithelioid 2Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Gemcitabine 17pembrolizumab 16Cisplatin 14enfortumab vedotin 7avelumab 7Nivolumab 6Docetaxel 6atezolizumab 5Paclitaxel 5Cystectomy 5sacituzumab govitecan 4durvalumab 4Mitomycin 4Cystoscopy 4Carboplatin 4vofatamab 3tremelimumab 3Radiotherapy 3Magnetic Resonance Spectroscopy 3vinflunine 2tisotumab vedotin 2poly ICLC 2cemiplimab 2aldesleukin 2Transurethral Resection of Bladder 2Radiotherapy, Intensity-Modulated 2Ipilimumab 2Interleukin-2 2Immunoglobulin G 2Clinical Trials, Phase II as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Urinary Bladder Neoplasms × Ifosfamide × Clear all
NCT00003105 2013-07-03

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
30 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡